about
Transglutaminases: nature's biological gluesIsolation and Characterization of a Cyclohexane-Metabolizing Xanthobacter spCeliac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell DynamicsSynthesis of potent water-soluble tissue transglutaminase inhibitors.RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signalingThe role of TG2 in regulating S100A4-mediated mammary tumour cell migrationTissue transglutaminase in cell death.Thioredoxin is involved in endothelial cell extracellular transglutaminase 2 activation mediated by celiac disease patient IgA.Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.Tissue transglutaminase (TG2)--a wound response enzyme.Transglutaminase and vascular biology: physiopathologic implications and perspectives for therapeutic interventions.Comparative study of the ability of three xanthobacter species to metabolize cycloalkanes.Tissue transglutaminase is an important player at the surface of human endothelial cells: evidence for its externalization and its colocalization with the beta(1) integrin.Inhibition of collagen I accumulation reduces glomerulosclerosis by a Hic-5-dependent mechanism in experimental diabetic nephropathy.Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.Transglutaminase 2 interaction with small heat shock proteins mediate cell survival upon excitotoxic stress.The effects of bleomycin and copper bleomycin upon transglutaminase enzymes.The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosisThe role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells.Unexpected role of surface transglutaminase type II in celiac disease.Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signalingInhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells.Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium.Activation of ERK1/2, JNK and PKB by hydrogen peroxide in human SH-SY5Y neuroblastoma cells: role of ERK1/2 in H2O2-induced cell death.Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity.Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress.Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion.Induction of tissue transglutaminase by dexamethasone: its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas.Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death.Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin.Assays for the measurement of tissue transglutaminase (type II) mediated protein crosslinking via epsilon-(gamma-glutamyl) lysine and N',N'-bis (gamma-glutamyl) polyamine linkages using biotin labelled casein.Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate.Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotidesDetection of epsilon(gamma-glutamyl) lysine.Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth.Cell cycle kinetics, tissue transglutaminase and programmed cell death (apoptosis).The existence of an inactive form of transglutaminase within metastasising tumours.Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells.Transglutaminase-catalysed cross-linking of proteins phosphorylated in the intact glucose-stimulated pancreatic beta-cell.
P50
Q24534936-D0A8F5AC-EA7D-4EB4-B8C0-F921DDA10529Q24655037-5A8F346C-317A-4C88-A1B6-C0521804A03FQ27316086-A011B893-5D81-4325-A16C-3B45A987C380Q33371436-79A13E9E-6E29-41C3-9C50-F0AAE1AB0989Q34401105-C15D72BB-5051-439D-BC87-AB665415BF9BQ34613001-9D86436F-9F6F-4869-9153-6FA95741438DQ34713452-98DC1159-69C8-489B-B06E-C00DF62F41C4Q35018831-D21DC151-CB01-4217-B182-76930C964653Q35803086-A843ACCF-E366-46B3-925E-FFBB2EEBC0F1Q36251098-D9F0ADCD-91C6-4373-A5E4-EA79E147F87CQ36266294-760448DB-AD52-4986-9942-F0C8F4783973Q36666756-8A24D5AF-D645-4722-A946-09996E19800FQ38320080-E9831D90-785A-4A59-9C43-DE25F0916BFAQ38397702-20830066-7D62-48EC-B800-5358B718A13BQ39094479-042ED38C-8F09-4344-9EB3-14A3304A7C4AQ39470547-1FD8CAC1-F2D4-4F30-B477-996818B7D37EQ39510066-AD7DB405-DA46-4569-B54D-A4F175DBEB16Q39636385-E1E4619A-934F-4EC9-BCE8-6BD6138BAC30Q39786237-970C42D6-61F7-486C-A8A2-ADF0876AF8CAQ40250104-CED977AF-6369-437D-8CAC-1945BFCDF1CFQ40351852-2B746797-9EE1-4A62-A672-9B3B85C04178Q40422808-F2D0C476-66C2-4EE5-A14D-F30A34E24E6BQ40522967-28D99239-E008-45C6-9961-1515F2C972FAQ40541035-15410962-50BB-4B5E-8646-96D927FD1FD9Q40598528-1C075D8F-3752-4836-B70D-A906C76F2E8FQ40676665-56472EE3-0DEF-4EAA-848E-9659F53910FCQ40725013-531E25F3-32D8-47B6-A2E0-E7EA9ACCDB4DQ40747981-305C1B92-2E51-4EE3-9BF7-1B8DBB7C5322Q41044018-2B875B68-494B-48D1-8553-6E14FC982438Q41057277-58B4F19C-87E6-49BD-97AE-218B5805FB8DQ41074541-6CCAE8A4-7B8E-4E77-B228-44396DAC16EEQ41129647-37B033A6-4EDE-4F09-98D8-428C31FB6C8EQ41170218-771590D6-022D-4398-A9E0-B5C31D440A0FQ41234678-2E0DE787-3022-405A-B77E-57EAE34C78CDQ41438382-0A75A828-0CF7-4577-8272-127678BDB32DQ41438808-1E19476A-C177-45DE-AC5F-FFCB18F99283Q41598379-7BB79386-8986-4710-B705-8599120ED723Q41731143-D88731B0-8AC8-49F5-9056-50BF73E228FBQ41756675-1F3A2482-FBC2-4EC7-BDD7-4B5E8197580FQ42048326-4D5C55D3-155E-4922-A36A-A43C2CFE4BE6
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin Griffin
@ast
Martin Griffin
@en
Martin Griffin
@es
Martin Griffin
@nl
Martin Griffin
@sl
type
label
Martin Griffin
@ast
Martin Griffin
@en
Martin Griffin
@es
Martin Griffin
@nl
Martin Griffin
@sl
prefLabel
Martin Griffin
@ast
Martin Griffin
@en
Martin Griffin
@es
Martin Griffin
@nl
Martin Griffin
@sl
P106
P21
P31
P496
0000-0003-3824-306X